
    
      This is a pilot study aiming at developing and optimizing MRI-based sequences to provide
      non-invasive quantification of intratumoral 2-hydroxyglutarate (2HG) distribution and tumor
      cellularity in human gliomas and help guide the development of novel glioma therapies.
    
  